This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Philip Morris Products S.a.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Vigen Onik Topuzyan: Innovator in Biologically Active Substances
Introduction
Vigen Onik Topuzyan is a notable inventor based in Yerevan, Armenia. He has made significant contributions to the field of biotechnology, particularly in the development of substrates for delivering biologically active substances. His innovative work has the potential to impact various applications in medicine and pharmaceuticals.
Latest Patents
Vigen holds a patent for a substrate designed for delivering a biologically active substance. This substrate comprises a cross-linked silicone matrix formed by cross-linking a silicone polymer using at least one crosslinking agent, which includes a tetraalkoxysilane. The cross-linked silicone matrix defines a plurality of domains, containing a composition that includes at least one monomeric glycol and at least one biologically active substance. This invention showcases his expertise in material science and its applications in health-related fields. He has 1 patent to his name.
Career Highlights
Vigen is currently employed at Philip Morris Products S.A., where he continues to innovate and develop new technologies. His work at this company allows him to collaborate with other experts in the field and contribute to advancements in product development.
Collaborations
Vigen has worked alongside talented colleagues such as Stepan Grigor Grigoryan and Mari Liova Atabekyan. Their collaborative efforts have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Vigen Onik Topuzyan is a distinguished inventor whose work in the field of biologically active substances is paving the way for future advancements. His contributions are significant, and his ongoing research promises to yield further innovations in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
